BridgeBio Pharma, Inc. (BBIO)
USD 25.98
(-6.61%)
USD 25.98
(-6.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.3 Million | 77.64 Million | 69.71 Million | 8.24 Million | 40.56 Million | - |
| Cost of Revenue | 2.44 Million | 3.43 Million | 3.11 Million | 3.08 Million | 2.5 Million | - |
| Gross Profit | 6.85 Million | 74.21 Million | 66.6 Million | 5.16 Million | 38.06 Million | - |
| Operating Expenses | 614.22 Million | 546.08 Million | 646.34 Million | 482.73 Million | 304.3 Million | 183.66 Million |
| Selling, General and Administrative Expenses | 150.59 Million | 143.18 Million | 192.21 Million | 145.68 Million | 94.35 Million | 43.58 Million |
| Research and Development Expenses | 455.71 Million | 402.89 Million | 454.13 Million | 337.04 Million | 209.94 Million | 140.07 Million |
| Other Expenses | 7.92 Million | 100.44 Million | 35.82 Million | 1.63 Million | -1.21 Million | -1.29 Million |
| Cost and Expenses | 616.67 Million | 546.08 Million | 646.34 Million | 482.73 Million | 306.8 Million | 183.66 Million |
| Operating Income | -607.37 Million | -471.87 Million | -579.74 Million | -474.48 Million | -266.24 Million | -183.66 Million |
| Interest Expense | 81.28 Million | 80.43 Million | 46.77 Million | 36.65 Million | 8.76 Million | 2.54 Million |
| Income Tax Expense | - | 9.31 Million | 52.84 Million | -21.56 Million | -28.14 Million | 16.75 Million |
| Earnings before Tax | -653.25 Million | -484.65 Million | -586.45 Million | -505.48 Million | -288.58 Million | -169.45 Million |
| Net Income | -643.2 Million | -493.96 Million | -639.29 Million | -483.92 Million | -260.43 Million | -130.74 Million |
| Earnings Per Share Basic | -3.95 | -3.35 | -4.43 | -4.10 | -2.48 | -1.42 |
| Earnings Per Share Diluted | -3.95 | -3.35 | -4.43 | -4.10 | -2.48 | -1.42 |
| Weighted Average Shares Outstanding | 162.79 Million | 147.47 Million | 144.35 Million | 117.99 Million | 105.09 Million | 92.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.79 Million | 147.47 Million | 144.35 Million | 117.99 Million | 105.09 Million | 92.33 Million |
| Gross Margin | 0.74 | 0.96 | 0.96 | 0.63 | 0.94 | - |
| EBIT Margin | -60.78 | -4.55 | -7.74 | -56.84 | -6.89 | - |
| Profit Margin | -69.14 | -6.36 | -9.17 | -58.66 | -6.42 | - |
| EBITDA | -565.46 Million | -397.44 Million | -533.83 Million | -465.74 Million | -279.82 Million | -183.41 Million |
| Earnings Before Tax Margin | -65.29 | -6.08 | -8.32 | -57.52 | -6.56 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.16 Million | 211.12 Million | 1.74 Million | 9.3 Million | 4.09 Million | 1.64 Million |
| Cost of Revenue | 1.87 Million | 1.89 Million | 598 Thousand | 2.44 Million | 598 Thousand | 599 Thousand |
| Gross Profit | 296 Thousand | 209.22 Million | 1.14 Million | 6.85 Million | 3.49 Million | 1.04 Million |
| Operating Expenses | 172.94 Million | 205.48 Million | 177.8 Million | 606.3 Million | 161.18 Million | 144.2 Million |
| Selling, General and Administrative Expenses | 58.24 Million | 64.51 Million | 47.58 Million | - | 35.77 Million | 36.12 Million |
| Research and Development Expenses | 114.69 Million | 140.97 Million | 130.22 Million | - | 125.13 Million | 108.08 Million |
| Other Expenses | 468 Thousand | 9.48 Million | 8.9 Million | 270 Thousand | 272 Thousand | 1.47 Million |
| Cost and Expenses | 174.81 Million | 207.37 Million | 178.4 Million | 608.74 Million | 161.78 Million | 144.2 Million |
| Operating Income | -172.64 Million | 3.74 Million | -177.41 Million | -607.37 Million | -157.69 Million | -146.09 Million |
| Interest Expense | 22.93 Million | 23.47 Million | 20.26 Million | 81.28 Million | -20.3 Million | 20.59 Million |
| Income Tax Expense | -2.08 Million | -944 Thousand | 18.35 Million | 71.51 Million | -1.63 Million | 19.26 Million |
| Earnings before Tax | -75.54 Million | -36.16 Million | -170.32 Million | -653.25 Million | -176.99 Million | -160.7 Million |
| Net Income | -73.45 Million | -35.21 Million | -168.14 Million | -643.2 Million | -176.99 Million | -157.89 Million |
| Earnings Per Share Basic | -0.39 | -0.20 | -0.96 | - | -1.08 | -0.98 |
| Earnings Per Share Diluted | -0.39 | -0.20 | -0.96 | - | -1.08 | -0.98 |
| Weighted Average Shares Outstanding | 187.58 Million | 178.7 Million | 174.46 Million | 162.79 Million | 163.3 Million | 160.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 187.58 Million | 178.7 Million | 174.46 Million | 162.79 Million | 163.3 Million | 160.53 Million |
| Gross Margin | 0.14 | 0.99 | 0.66 | 0.74 | 0.85 | 0.63 |
| EBIT Margin | -78.91 | 0.03 | -96.98 | - | -38.55 | -82.23 |
| Profit Margin | -33.88 | -0.17 | -96.36 | -69.14 | -43.27 | -96.22 |
| EBITDA | -171.07 Million | 5.33 Million | -169.22 Million | - | -157.69 Million | -134.94 Million |
| Earnings Before Tax Margin | -79.63 | 0.02 | -101.67 | -65.29 | -38.55 | -89.03 |
SECOY
OIII
4043
TCIIF
2901
BCO